Dalosirvat clinical trials
How each study uses dalosirvat is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Topical SM04554 solution
- 2
Studies by the year they started
3 studies that test it; most in 2014 (1)
| Year | Studies |
|---|---|
| 2014 | 1 |
| 2015 | 1 |
| 2018 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Studies
Open first, then newest update. How each study uses dalosirvat is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- A Study of the Safety, Tolerability, and Efficacy of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia (AGA)CompletedPhase 2Biosplice Therapeutics, Inc.NCT02275351Written as Topical SM04554 solution
- A Study Evaluating the Efficacy and Safety of SM04554 Topical Solution in Male Subjects With Androgenetic AlopeciaCompletedPhase 2/3Biosplice Therapeutics, Inc.NCT03742518Written as Topical SM04554 0.15% solution
- A Study of SM04554 Applied Topically to the Scalp of Male Subjects With Androgenetic Alopecia Analyzed by Biopsy of the Scalp Prior To and Post DosingCompletedPhase 2Biosplice Therapeutics, Inc.NCT02503137Written as Topical SM04554 solution
Codes
What other systems call dalosirvat · ClinicalTrials.gg INT017723
- UNII (FDA) QX6T87A52IDALOSIRVATConfirmed FDA, Wikidata
- Wikidata Q105335037dalosirvatConfirmed FDA, Wikidata
- NCI Thesaurus C175762DalosirvatOne source FDA
- DrugBank DB18960One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | QX6T87A52I | DALOSIRVAT | Confirmed FDA, Wikidata |
| Wikidata | Q105335037 | dalosirvat | Confirmed FDA, Wikidata |
| NCI Thesaurus | C175762 | Dalosirvat | One source FDA |
| DrugBank | DB18960 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.